why choose us

First received: February 13, 2023

Clinical Trial: African Cancer Genome: GMD

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Breast Cancer
Prostate Cancer

Study Type: OBSERVATIONAL


Official Title: African Cancer Genome Cohort to Promote Health Equity Among Patients of African Ancestry: Characterization of Genetic and Molecular Drivers

Brief Summary: The goal of this study is to develop a comprehensive characterization of genetic and molecular drivers of breast and prostate cancer in individuals of African ancestry. The study is conducted by the African Caribbean Cancer Consortium (AC3) and involves the recruitment of patients from nine international AC3 research sites in the Bahamas, Barbados, Benin, Burkina Faso, Haiti, Jamaica, Kenya, Namibia, and Trinidad and Tobago, and the US. The main questions are to: molecularly characterize genomic changes in the…

Read more